Patent Assignment
Reel/Frame 074915/0310
Change of Name
Recorded: 2026-06-10
Pages: 5
Assignor
ASOCURA PHARMACEUTICALS SUZHOU CO., LTD
Executed: 2024-12-05
Assignee
ASOCURA PHARMACEUTICALS GUANGZHOU CO., LTD
NO. 188 KAIYUAN AVENUE, ROOM 701, BUILDING 15, HUANGPU DISTRICT, GUANGZHOU, 510530, CHINA
Covered Properties
(2)
Antisense Oligonucleotide, Compositions and Pharmaceutical Formulations Thereof for Exon Skipping
Application:
19/116,328 →
Publication:
US 2026/0117232
Antisense Oligonucleotides and Their Use for Treating Pendred Syndrome
Related Assignments
(4)
Other recorded transfers of the patents in this record — the chain of ownership.
Assignment of Assignor's Interest
Dec 6, 2021
From: HUA, YIMIN
To: ACCUTAR BIOTECHNOLOGY INC.
Reel/Frame 058310/0872 →
Assignment of Assignor's Interest
Dec 6, 2021
From: ACCUTAR BIOTECHNOLOGY INC.
To: HUA, YIMIN
Reel/Frame 058310/0972 →
Assignment of Assignor's Interest
Dec 6, 2021
From: HUA, YIMIN
To: ASOCURA PHARMACEUTICALS SUZHOU CO., LTD.
Reel/Frame 058311/0117 →
Assignment of Assignor's Interest
Apr 15, 2025
From: HUA, YIMIN; FENG, PENGCHAO
To: ASOCURA PHARMACEUTICALS SUZHOU CO., LTD.
Reel/Frame 070844/0046 →